The Venezuelan Health Ministry approved Russia’s single-dose Sputnik Light vaccine against the coronavirus for use in the country, the Russian Direct Investment Fund (RDIF) said Saturday.
“The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of the Russian single-dose Sputnik Light vaccine against coronavirus by the Ministry of Health of the Bolivarian Republic of Venezuela,” the RDIF said in a statement.
Sputnik Light is the first component of the Sputnik V vaccine, which was approved in Venezuela in January 2021 under the emergency use authorization.
“Sputnik Light demonstrated 79.4% efficacy according to analyzed data taken from 28 days after the injection was administered,” the RDIF says.
Russia registered the single-dose Sputnik Light vaccine with 79.4% efficacy, developed as Sputnik V by the Gamaleya Research Institute, in May. It is efficient against all COVID-19 strains and has no registered complication cases after its administration.